ABSTRACT To investigate the etiopathogenesis of fatty liver hemorrhagic syndrome (FLHS) and the protective effects of soybean lecithin against FLHS in laying hens, 135 healthy 300-day-old Hyline laying hens were randomly divided into groups: control (group 1), diseased (group 2), and protected (group 3). Each group contained 45 layers with 3 replicates. The birds in these 3 groups were fed a control diet, a high-energy/lowprotein (HELP) diet or the HELP diet supplemented with 3% soybean lecithin instead of maize. The fat percent in the liver was calculated. Histopathological changes in the liver were determined by staining, and the mRNA expression levels of apolipoproteinA I (apoA I) and apolipoprotein B 100 (apoB 100 ) in the liver were determined by RT-PCR. The results showed that the fat percent in the liver of group 2 was much higher (P < 0.01) than that of group 1 and group 2 on d 30 and 60. The histology of the liver in group 2 on d 30 and 60 displayed various degrees of liver lesions, while the hepatocytes showed a normal structure in group 3 with mild microvesicular steatosis in the liver cell on d 30 and 60. The mRNA expression levels of apoA I and apoB 100 in the livers were variable throughout the experiment. The expression level of apoA I in group 2 significantly decreased on d 60 (P < 0.05); the expression level of apoB 100 slightly increased on d 30 in group 2, while it sharply decreased on d 60. Compared to group 1, the expression level of apoB 100 showed no significant difference in group 3 (P < 0.05). This study indicated that FLHS induced pathological changes and abnormal expression of apoA I and apoB 100 in the livers of laying hens and that soybean lecithin alleviated these abnormal changes.
INTRODUCTION
Fatty liver hemorrhagic syndrome (FLHS) is a type of lipid metabolism disorder in layers, which affects poultry health and results in economic loss (Aydin, 2005; Thomson et al., 2003) . There are many factors leading to FLHS, such as nutritional, genetic, hormonal, environmental, and metabolic inputs (Schuman et al., 2000; Choi et al., 2012) . FLHS is characterized by an excess accumulation of fat in the liver along with a hemorrhagic and pale liver, and it can even result in sudden death if the liver ruptures and causes internal bleeding (Diaz et al., 1999; Yousefi et al., 2005) . When excess fat accumulates in the liver, the lipoprotein metabolism is changed. It has been reported that chickens suffer from fatty liver when lipoprotein transport is disrupted, and overproduction of lipoproteins by the liver leads to lipid metabolism disorders (Aydin, 2005) . Very-lowdensity lipoprotein (VLDL) and high-density lipoprotein (HDL) are the main forms of lipoprotein particles synthesized in the liver. Apolipoprotein B 100 (apoB 100 ) and apolipoprotein A I (apoA I) are the major apolipoproteins of chicken VLDL and HDL (Hermier, 1997) . Previous studies confirmed that apoA I and apoB 100 are associated with lipid metabolism. ApoA I is the major apolipoprotein in HDL, and it plays an important role in regulating the cholesterol content of peripheral tissues through the reverse cholesterol transport pathway. Thus, apoA I participates in lipid metabolism (Gu et al., 1993; Sontag et al., 2012) . ApoB 100 is synthesized in the liver, and it is critical for the transportation of lipids and the deposition of 3559 adipose tissues, which are both associated with fatty liver (Pullinger et al., 1989; Basiricò et al., 2010) .
Many studies have been conducted to find effective supplements that can prevent FLHS. Soybean lecithin (SL), a by-product from the processing of soybeans, is used widely in broilers and laying hens for its abundant nutrition and low cost (Aznan and Ciftci, 2004) . Previous studies have suggested that SL has the potential to enhance the utilization of dietary fat and modify lipid metabolism by affecting hepatic triglycerides (Huang et al., 2008; Herland and Sundst, 1994) . However, the mechanism of regulation of lipid metabolism by SL is still unclear. Thus, to determine the effects of soybean lecithin on lipid metabolism, histopathological changes in the liver were observed, the fat percent in liver was determined, and the mRNA expression levels of 2 apolipoprotein genes (apoA I and apoB 100 ) were tested after SL treatment.
MATERIALS AND METHODS

Animals and Diets
All experimental protocols were approved by the Committee for the Care and Use of Experimental Animals, Jiangxi Agricultural University, Jiangxi, China.
A total of 135 healthy, 300-day-old Hyline layers were randomly divided into 3 groups and were fed the same basal diet that was formulated to meet the nutritional requirements of layers (NRC, 1998) (Zheng et al., 2010) . The 3 groups included group 1 (control group, fed a basal diet), group 2 (diseased group, fed a HELP diet) and group 3 (protected group, fed a HELP diet with 3% SL instead of maize). The ingredient and nutrient levels of the diets in each group is shown in Table 1 . All layers were acclimatized for 1 week before the start of the experiment. The layers were given free access to water and kept in cages. The experiment lasted for 60 d.
Sampling Procedures
On d 0, 30, and 60, the layers were anesthetized and then euthanized after treatment. The livers were removed from 9 randomly selected layers in each group after they were sacrificed humanely. The livers were weighed, and the fat percent in the liver was determined by the Soxhlet extraction method (Krishan et al., 2014) . The remaining livers were used to measure the mRNA expression levels of apoA I and apoB 100 .
Real-time Quantitative Polymerase Chain Reaction
Gene expression levels were assessed by real-time quantitative polymerase chain reaction (RT-qPCR). 3 Treatment diets: group 1 (control group, fed a basal diet), group 2 (diseased group, fed a HELP diet) and group 3 (protected group, fed a HELP diet with 3% SL instead of maize).
Primers for the amplification of apoA I and apoB 100 genes were designed using Primer Premier Software (PREMIER Biosoft International, CA). The primer sequences and GenBank accession numbers were obtained from GenBank ( Table 2 ). The protocol used for the amplification of the PCR products consisted of denaturation at 95
• C for 30 s, followed by 40 cycles of amplification at 94
• C for 10 s and 60
• C for 30 s, and extension at 72
• C for 30 s. At the end of the PCR protocol, melting curve analyses were performed for all genes. All reactions were performed on an ABI 7500 real-time PCR machine (Applied Biosystems, Beijing, China); then, the resulting amplification data were analyzed using 7500 Sequence Detection System (SDS) software (Applied Biosystems, Beijing, China). Relative genes expression levels were calculated based on qPCR efficiency (E) and difference in the cycle threshold (ΔCt) of the treated versus control groups for both target and reference genes according to the formula: Ratio -ΔΔCT which was used to determine the gene expression levels of the samples. Figure 1 . The fat percent in liver (%).
a,b,c P < 0.05. A,B,C P < 0.01. group 1 (control group, fed a basal diet), group 2 (diseased group, fed a HELP diet) and group 3 (protected group, fed a HELP diet with 3% SL instead of maize).
Histopathological Examination
The liver tissues were dissected, rinsed with saline and then fixed in 10% neutral buffered formalin. The formalin-fixed samples were routinely processed, embedded in paraffin, sectioned at 5 μm, and stained with hematoxylin and eosin (H&E). The stained sections were observed using an optical microscope, and photographs were taken.
Statistical Analysis
Statistical evaluation of the data was performed by one-way analysis of variance followed by Duncan's multiple range test when the P-value was significant; uppercase letters (A, B, and C) denote that the differences are highly significant and lowercase letter (a, b and c) denote that the differences are significant. All analyses were performed using the Statistical Package for the Social Sciences (SPSS) for Windows. Values are presented as the mean ± SD. Differences with P < 0.05 were considered statistically significant; P < 0.01, highly significant.
RESULTS
Effects of SL on the Fat Percent in the Liver
The results from the analysis of fat percent (Figure 1) showed that there were no significant differences among the 3 groups on d 0. The fat percent of group 2 was much higher (P < 0.01) than that of group 1 and group 3 on d 30 and 60. The increase in group 3 was milder than in group 2 on d 30 and 60.
Histopathological Observations of the Liver
Histopathological changes in the liver were observed in this study. As the H&E staining showed, group 2 (diseased group, fed a HELP diet) had different degrees of pathological changes (black arrowhead) compared with group 1. The histology of the livers in group 1 displayed regular hepatic sinusoids and normal hepatic cords (Figure 2) . However, the histology of the livers in group 2 on d 30 demonstrated liver lesions, with microvesicular steatosis (less than 50% of the hepatocytes containing vacuoles of any size). Furthermore, more severe lesions were observed (50% or more of the greater hepatocytes containing vacuoles of variable sizes or diffused vacuolization with small vacuoles) in the hepatocytes on d 60 (Figure 2) . The hepatocytes in group 3 displayed regular hepatic sinusoids and normal hepatic cords. There were a few cases of microvesicular steatosis in the liver on d 30 and 60 (Figure 2 ).
Expression of apoA I and apoB 100 Genes in the Livers
The RT-PCR products of the genes (β-actin, apoA I and apoB 100 ) were analyzed by electrophoresis. The data showed that apoA I mRNA expression (Figure 3 ) in the livers was decreased in group 2 on d 30 (P > 0.05) and 60 (P < 0.01) compared to that in group 1. However, apoA I mRNA expression was not significantly different in group 3 (P > 0.05) during the experimental period. On d 30, apoB 100 mRNA expression (Figure 4 ) in liver the liver was not significantly different (P > 0.05) among the 3 groups while expression was decreased in group 2 on d 60 (P < 0.01). The expression in group 3 was not significantly different from that in group 1 (P > 0.05).
DISCUSSION
FLHS is a metabolic disorder that leads to an increase in mortality among adult layers and often causes a sudden drop in egg production, which is harmful to the health of the birds and results in economic losses (Aydin, 2005; Thomson et al., 2003) . The syndrome is known to be caused by many factors, including Magnification, 400×. group 1 (control group, fed a basal diet), group 2 (diseased group, fed a HELP diet) and group 3 (protected group, fed a HELP diet with 3% SL instead of maize). A,B,C P < 0.01. group 1 (control group, fed a basal diet), group 2 (diseased group, fed a HELP diet) and group 3 (protected group, fed a HELP diet with 3% SL instead of maize).
nutrients (Lee et al., 2010) . It was reported that a highenergy/low-protein (HELP) diet could cause FLHS in laying hens (Guo et al., 2010) ; the HELP diet was also reported as a natural cause of FLHS (Rozenboim et al., 2016) . Thus, we used a HELP diet to generate a model of FLHS.
In the present study, the fat percent in the liver was determined. The results showed that the fat percent in the liver were increased in layers that fed the HELP diet A,B,C P < 0.01. group 1 (control group, fed a basal diet), group 2 (diseased group, fed a HELP diet) and group 3 (protected group, fed a HELP diet with 3% SL instead of maize).
(group 3), indicating that HELP diet increased the fat percent in the liver. The results were also supported by a previous study (Rozenboim et al., 2016) . In the current study, large intracoelomic blood clots were found on the left and right liver lobes in group 3. Analysis of the liver by tissue sectioning and H&E staining further showed that the HELP diet induced micro-vesicular steatosis in the layers, which indicated that FLHS occurred in group 3. A similar result was obtained by Trott and colleagues, in which they found different degrees of changes in the liver of layers fed a LPHF diet (Trott et al., 2014) . In addition, the increase in the fat percent in the liver of the SL treatment group (group 2) was not as substantial as that in group 3. The increase in group 2 was milder, indicating that SL could reduce the accumulation of fat in the liver. Furthermore, analysis of the liver sections showed that the changes in group 2 were negligible, which confirmed that the liver was not affected by FLHS the SL-treatment group. This result was supported by a previous that used SL to improve dietary lipid utilization by enhancing lipase and phospholipase activities (Saleh et al., 2015) . It was also reported that a lecithin-rich diet could modify hepatic cholesterol homeostasis and lipoprotein metabolism (LeBlanc et al., 2003) . The results confirmed that FLHS induced pathological changes while hepatocyte steatosis was improved by the addition of SL.
In our study, the expression levels of apoA I and apoB 100 in the hepatic tissues were variable between the layers in the HELP diet-fed group (group 2). The expression levels of apoA I and apoB 100 were decreased in the hepatic tissues. This decrease may be caused by liver injury from FLHS. In group 2, the expression levels of apoA I and apoB 100 were not significant in the hepatic tissues. This finding indicated that the diet supplemented with SL could protect the liver by modifying hepatic cholesterol homeostasis and lipoprotein metabolism. A previous study demonstrated that SL could modulate lipid metabolism (LeBlanc et al., 2003) . The present study revealed that FLHS could induce the abnormal expression of apoA I and apoB 100 in the liver, and that SL could improve the abnormal changes in the livers of laying hens.
